BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 8819528)

  • 1. Cellular and metabolic basis of Clara cell tolerance to multiple doses of cytochrome P450-activated cytotoxicants. I: Bronchiolar epithelial reorganization and expression of cytochrome P450 monooxygenases in mice exposed to multiple doses of naphthalene.
    Lakritz J; Chang A; Weir A; Nishio S; Hyde D; Philpot R; Buckpitt A; Plopper C
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1408-18. PubMed ID: 8819528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. IV. Metabolism of naphthalene and naphthalene oxide in microdissected airways from mice, rats, and hamsters.
    Buckpitt A; Chang AM; Weir A; Van Winkle L; Duan X; Philpot R; Plopper C
    Mol Pharmacol; 1995 Jan; 47(1):74-81. PubMed ID: 7838135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. III. Morphometric comparison of changes in the epithelial populations of terminal bronchioles and lobar bronchi in mice, hamsters, and rats after parenteral administration of naphthalene.
    Plopper CG; Macklin J; Nishio SJ; Hyde DM; Buckpitt AR
    Lab Invest; 1992 Nov; 67(5):553-65. PubMed ID: 1434534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of cytochrome P-450 activity to Clara cell cytotoxicity. I. Histopathologic comparison of the respiratory tract of mice, rats and hamsters after parenteral administration of naphthalene.
    Plopper CG; Suverkropp C; Morin D; Nishio S; Buckpitt A
    J Pharmacol Exp Ther; 1992 Apr; 261(1):353-63. PubMed ID: 1560379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism and cytotoxicity of naphthalene and its metabolites in isolated murine Clara cells.
    Chichester CH; Buckpitt AR; Chang A; Plopper CG
    Mol Pharmacol; 1994 Apr; 45(4):664-72. PubMed ID: 8183245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naphthalene cytotoxicity of differentiating Clara cells in neonatal mice.
    Fanucchi MV; Buckpitt AR; Murphy ME; Plopper CG
    Toxicol Appl Pharmacol; 1997 May; 144(1):96-104. PubMed ID: 9169074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic activation and bronchiolar Clara cell necrosis from naphthalene in the isolated perfused mouse lung.
    Kanekal S; Plopper C; Morin D; Buckpitt A
    J Pharmacol Exp Ther; 1990 Jan; 252(1):428-37. PubMed ID: 2299600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated airway GSH resynthesis confers protection to Clara cells from naphthalene injury in mice made tolerant by repeated exposures.
    West JA; Buckpitt AR; Plopper CG
    J Pharmacol Exp Ther; 2000 Aug; 294(2):516-23. PubMed ID: 10900227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated susceptibility to 4-ipomeanol cytotoxicity in immature Clara cells of neonatal rabbits.
    Plopper CG; Weir AJ; Nishio SJ; Chang A; Voit M; Philpot RM; Buckpitt AR
    J Pharmacol Exp Ther; 1994 May; 269(2):867-80. PubMed ID: 8182556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maintenance of differentiated murine Clara cells in microdissected airway cultures.
    Van Winkle LS; Buckpitt AR; Plopper CG
    Am J Respir Cell Mol Biol; 1996 Jun; 14(6):586-98. PubMed ID: 8652187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 2B1 immunoreactivity in bronchiolar and alveolar epithelial cells after exposure of rats to ozone.
    Takahashi Y; Aida S; Suzuki E; Ito Y; Miura T; Kimula Y
    Toxicol Appl Pharmacol; 1994 Oct; 128(2):207-15. PubMed ID: 7940535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tolerance to multiple doses of the pulmonary toxicant, naphthalene.
    O'Brien KA; Suverkropp C; Kanekal S; Plopper CG; Buckpitt AR
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):487-500. PubMed ID: 2749735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of cytochrome P450 activity to Clara cell cytotoxicity. II. Comparison of stereoselectivity of naphthalene epoxidation in lung and nasal mucosa of mouse, hamster, rat and rhesus monkey.
    Buckpitt A; Buonarati M; Avey LB; Chang AM; Morin D; Plopper CG
    J Pharmacol Exp Ther; 1992 Apr; 261(1):364-72. PubMed ID: 1560380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for hepatic formation, export and covalent binding of reactive naphthalene metabolites in extrahepatic tissues in vivo.
    Buckpitt AR; Warren DL
    J Pharmacol Exp Ther; 1983 Apr; 225(1):8-16. PubMed ID: 6834280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated inhalation exposures to the bioactivated cytotoxicant naphthalene (NA) produce airway-specific Clara cell tolerance in mice.
    West JA; Van Winkle LS; Morin D; Fleschner CA; Forman HJ; Plopper CG
    Toxicol Sci; 2003 Sep; 75(1):161-8. PubMed ID: 12805647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repair of naphthalene-injured microdissected airways in vitro.
    Van Winkle LS; Isaac JM; Plopper CG
    Am J Respir Cell Mol Biol; 1996 Jul; 15(1):1-8. PubMed ID: 8679213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse specific lung tumors from CYP2F2-mediated cytotoxic metabolism: an endpoint/toxic response where data from multiple chemicals converge to support a mode of action.
    Cruzan G; Bus J; Banton M; Gingell R; Carlson G
    Regul Toxicol Pharmacol; 2009 Nov; 55(2):205-18. PubMed ID: 19589367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covalent interactions of reactive naphthalene metabolites with proteins.
    Cho M; Chichester C; Morin D; Plopper C; Buckpitt A
    J Pharmacol Exp Ther; 1994 May; 269(2):881-9. PubMed ID: 8182557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung.
    Kanekal S; Plopper C; Morin D; Buckpitt A
    J Pharmacol Exp Ther; 1991 Jan; 256(1):391-401. PubMed ID: 1988668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic and pulmonary microsomal metabolism of naphthalene to glutathione adducts: factors affecting the relative rates of conjugate formation.
    Buckpitt AR; Bahnson LS; Franklin RB
    J Pharmacol Exp Ther; 1984 Nov; 231(2):291-300. PubMed ID: 6491983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.